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The Interplay of Type I and Type II
Interferons in Murine Autoimmune
Cholangitis as a Basis for Sex-Biased
Autoimmunity
Heekyong R. Bae,1 Deborah L. Hodge,1 Guo-Xiang Yang,2 Patrick S.C. Leung,2 Sathi Babu Chodisetti,3
Julio C. Valencia,1 Michael Sanford,1 John M. Fenimore,1 Ziaur S.M. Rahman,4 Koichi Tsuneyama,5
Gary L. Norman ,6 M. Eric Gershwin,2 and Howard A. Young1
We have reported on a murine model of autoimmune cholangitis, generated by altering the AU-rich element (ARE) by dele-
tion of the interferon gamma (IFN-c) 3’ untranslated region (coined ARE-Del2/2), that has striking similarities to human
primary biliary cholangitis (PBC) with female predominance. Previously, we suggested that the sex bias of autoimmune chol-
angitis was secondary to intense and sustained type I and II IFN signaling. Based on this thesis, and to define the mecha-
nisms that lead to portal inflammation, we specifically addressed the hypothesis that type I IFNs are the driver of this
disease. To accomplish these goals, we crossed ARE-Del2/2 mice with IFN type I receptor alpha chain (Ifnar1) knockout
mice. We report herein that loss of type I IFN receptor signaling in the double construct of ARE-Del2/2 Ifnar12/2 mice
dramatically reduces liver pathology and abrogated sex bias. More importantly, female ARE-Del2/2 mice have an increased
number of germinal center (GC) B cells as well as abnormal follicular formation, sites which have been implicated in loss of
tolerance. Deletion of type I IFN signaling in ARE-Del2/2 Ifnar12/2 mice corrects these GC abnormalities, including
abnormal follicular structure. Conclusion: Our data implicate type I IFN signaling as a necessary component of the sex bias
of this murine model of autoimmune cholangitis. Importantly these data suggest that drugs that target the type I IFN sig-
naling pathway would have potential benefit in the earlier stages of PBC. (HEPATOLOGY 2018;67:1408-1419)
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I
nterferon gamma (IFN-c) is an inflammation
modulator regulating both proinflammatory and
anti-inflammatory responses, and its expression is
critical for the initial host innate immune response and
is also essential to mount an adaptive immune
response. Over expression of IFN-c has been demon-
strated as a key factor in the induction of autoimmu-
nity. Of note, it has been found that IFN-c also plays
an essential role in the development and severity of
female dominant autoimmune diseases.(1,2) Our group
has produced several lines of evidence that IFN-c is
involved in the pathogenesis of both murine model
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and human primary biliary cholangitis (PBC).(3-7) In
particular, we have taken advantage of a “designer”
mouse with posttranscriptional dysregulation of IFN-c
through deletion of the IFN 3’ untranslated region (3’-
UTR) AU-rich element (ARE2/2). These animals,
coined ARE2/2 mice, exhibit prolonged and chronic
overexpression of IFN-c and, more important, develop
a female predominant autoimmune cholangitis, with
portal inflammation, liver granulomas, elevation of bile
salts, elevation of sera immunoglobulin (Ig) M, and
the presence of both antimitochondrial antibodies
(AMAs) and antibodies to gp210.(8)
We propose that IFN-c is critically involved with
sex bias. Previous analysis of differentially expressed
genes in female ARE-Del2/2 mice revealed stronger
type I and II IFN signaling and lymphocyte-mediated
immune responses, especially CD4T-cell-mediated
responses. Type I IFN receptors were detected as one
of the top upstream regulators next to IFN-c in liver
gene expression analysis.(8) Therefore, to extend these
pilot observations and define a translational application
to human PBC, we developed IFNa/b receptor alpha-
chain–deficient ARE-Del2/2 animals, coined ARE-
Del2/2 Ifnar12/2 mice. Herein, we report that deple-
tion of type I IFN signaling significantly prevents the
female-prevalent autoimmune cholangitis phenotype,
including portal and lobular duct inflammation, granu-
loma formation, bile duct damage, and elevation of
total bile acids. Furthermore, these mice with deficient
type I IFN signaling no longer manifest abnormal fol-
licular T helper (Tfh) cells and germinal centers (GC)
formation found in ARE-Del2/2 mice. Therefore, we
propose that cross-talk between IFN signaling and Tfh
and B cells found in GCs are critical to loss of toler-
ance and female predominance.(9-11) Furthermore,




ARE-Del2/2 mice were generated and maintained
as reported.(8,12) Ifnar12/2 mice were initially obtained
from The Jackson Laboratory and back-crossed onto
the C57BL/6 background by speed congenic analysis.
For generating Ifnar12/2ARE-Del2/2 mice, male
ARE-Del1/2 mice were mated with female Ifnar12/2
mice to obtain male ARE-Del1/2 IFN type I receptor
alpha chain (Ifnar1)1/2 mice, which were subsequently
back-crossed with female Ifnar12/2 mice to obtain
ARE-Del2/2 Ifnar12/2 mice. The parental ARE-
Del2/2 and the derived ARE-Del2/2 Ifnar12/2 mice
were genotyped at 3-4 weeks of age to confirm the
ARE-Del and knockout (KO) Ifnar1 genes in their
genomic DNA. Animal care was provided in accord
with the procedures outlined in the Guide for Care
and Use of Laboratory Animals (National Research
Council; 2011; National Academy Press, Washington,
DC). At serial ages, animals were sacrificed to collect
sera, spleen, and liver tissues for serological, gene
expression, and cellular immunological analysis. The
experimental protocols were approved by the National
Cancer Institute at Frederick and the University of
California Animal Care and Use Committee. All
experiments were performed in group sizes of 4-10
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and replicated at least twice; the numbers in each
experiment are noted in the figure legends.
ANTIMITOCHONDRIAL AND
ANTI-SP100 AUTOANTIBODIES
IgM and IgG anti-PDC-E2 (pyruvate dehydroge-
nase complex component E2) assays were performed
by enzyme-linked immunosorbent assay (ELISA) with
data presented as optical density (O.D.)6 SEM, as
described, with known positive and negative controls
and standardized recombinant PDC-E2.(5,13,14) Anti-
bodies to SP100 were evaluated by ELISA using
INOVA kits (INOVA Diagnostics, San Diego, CA)
and again including known controls.(15,16)
TOTAL BILE ACID ANALYSIS
Total bile acid (TBA) was analyzed using freshly
collected serum and a Total Bile Acid Enzymatic
Cycling Assay Kit (Diazyme, Poway, CA), as
described.(8) Data were acquired in a kinetic scan mode
using the 405-nm wavelength in 1-minute intervals.
DA405/min was calculated for standard, control, blank
(DDW with R2), and samples by subtracting the
O.D. value at each interval; DA405/min was consistent
at all intervals. The concentration of TBA was then
quantitated as described.(8)
PEPTIDE ARRAY
Autoantigen arrays with immobilized synthetic pep-
tides were generated by PEPperPRINT (Heidelberg,
Germany). Arrays were hybridized with serum from
ARE-Del2/2 mice after blocking, and the autoanti-
bodies bound to their corresponding peptides on the
array were detected with fluorophore-conjugated sec-
ond antibodies against different isotypes of autoanti-
bodies (IgG and IgM). Each microarray image was
quantified by PepSlide Analyzer and statistical signifi-
cance determined using the Holm-Sidak method, with
alpha5 5.000%
CELL ISOLATION AND FLOW
CYTOMETRY ANALYSIS
Mononuclear cells (MNCs) were isolated from
spleen.(17,18) For cell-surface staining, 13 106 MNCs
were resuspended in staining buffer (0.2% bovine
serum albumin, 0.04% ethylenediaminetetraacetic acid,
and 0.05% sodium azide in phosphate-buffered saline),
divided into 25-mL aliquots, and incubated with anti-
mouse FcR blocking reagent (eBioscience, San Diego,
CA) for 15 minutes at 4 8C. Cells were washed and
stained for 30 minutes at 4 8C with cocktails contain-
ing combinations of fluorochrome conjugated mono-
clonal antibody (mAbs) for cell-surface markers CD4
(GK1.5), CD8a (53-6.7), B220 (RA3-6B2), pro-
grammed cell death 1 (PD-1; 29F.1A12), CD95
(FAS, Jo2), GL-7 (GL7), and C-X-C chemokine
receptor type (CXCR) 5 (2G8). All reagents were pur-
chased from BioLegend (San Diego, CA) and optimal
dilutions used throughout with positive and negative
controls.
HISTOPATHOLOGY
Portions of livers were excised immediately upon
sacrifice and fixed in 10% paraformaldehyde solution
for 2 days at room temperature, embedded in paraffin,
cut into 4-lm sections, and deparaffinized for routine
hematoxylin and eosin (H&E) staining.(19) Whole
spleens were excised and embedded in paraffin and cut
into horizontal sections and deparaffinized for H&E
and peanut agglutinin (PNA) staining. Each histologi-
cal score means the sum of severity and frequency




Spleen cells were collected from 20-week-old female
ARE-Del2/2 and wild-type (WT) mice. MNCs were
isolated from spleen and CD41 T cells purified by
negative selection with microbeads and MiniMacs
separation columns (Miltenyi Biotec, Auburn, CA).
Ten-week-old female C57BL6 mice were used as
recipients. Aliquot of 13 106 CD41 T cells were
transferred into recipient mice by tail vein injection as
described.(8,22) Eight weeks after cell transfer, mice
were sacrificed and splenic cells collected to analyze
Tfh and GC B cells by flow cytometric analysis. Livers
were collected from recipient mice for pathological
analysis.
STATISTICAL ANALYSIS
One-way analysis of variance (ANOVA), two-tailed
unpaired t test, and nonparametric Mann-Whitney U
test were used for analysis. P values< 0.05 were con-
sidered statistically significant.





AMELIORATED BY DELETION OF
THE Ifnar1 GENE IN ARE-Del2/2
MICE
We first compared histological changes in liver sam-
ples of both sex double-knockout ARE-Del2/2
Ifnar12/2 mice with ARE-Del2/2 mice. Figure 1A
demonstrates that ARE-Del2/2 mice have distinct
lymphocyte infiltration near the portal tracts with dis-
ruption of small bile ducts that are more severe in
female mice. The histological scores of inflammation
demonstrate the severities in specific regions, including
bile duct disruption, granuloma formation, and portal
and lobular inflammation, in the liver of each strain of
mice (Fig. 1B). Female ARE-Del2/2 mice manifest
increased inflammation in these regions compared to
male ARE-Del2/2 mice, and although this inflamma-
tion was significantly suppressed by the depletion of
type I IFN receptor, it did not completely delete chol-
angitis and revert to the same levels as WT and
Ifnar12/2 control littermates. However, removal of the
Ifnar1 gene distinctively ameliorated the sex difference
in the severity of inflammation between male and
female ARE-Del2/2 Ifnar12/2 mice. The reductions
in liver pathology by deletion of the Ifnar1 gene were
also exhibited in heterozygous ARE-Del1/2 Ifnar12/2
mice and male ARE-Del mice. However, because the
disease is minimal in these groups, the overall reduc-
tions are minimal (data not shown). Thus, although
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FIG. 1. Deletion of the Ifnar1 gene suppresses female-biased pathological phenotypes in ARE-Del2/2 mice. (A) Representative
H&E staining of female Ifnar12/2, ARE-Del2/2, ARE-Del2/2Ifnar12/2 mice compared to control (WT) littermates. (B) Pathologi-
cal score of liver histology of portal inflammation, lobular inflammation, biliary duct damage, and granuloma formation. Statistical
analysis was performed by the nonparametric Mann Whitney U test using GraphPad Prism software (version 6.0; GraphPad Software
Inc., La Jolla, CA;mean6 SEM; n5 7-8). The two-tailed P value< 0.05 was taken as significance (*P< 0.05; **P< 0.01;
***P< 0.001, n.s., not significant).
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chronic expression of IFN-c elicit cholangitis in both
sexes, type I IFN signaling is critical for sex-biased
PBC-like lesions. ARE-Del2/2 Ifnar12/2 mice, com-
pared to ARE-Del1/2 Ifnar12/2 mice, manifest less
disease, implying that threshold levels of type II IFN
may overcome the loss of type I IFN signaling.
TOTAL BILE SALTS AND
SEROLOGICAL MARKERS OF PBC
WERE SUPPRESSED BY
DELETION OF THE Ifnar1 GENE
IN FEMALE ARE-Del2/2 MICE
Increased levels of total bile acids (TBAs) and
AMAs are the characteristic serological markers for
PBC. To determine the role of type I IFN in the
expression of these markers, we first measured serum
TBA in ARE-Del2/2 Ifnar12/2, compared to ARE-
Del2/2, mice (Fig. 2). Consistent with our previous
report,(8) female ARE-Del2/2 mice have higher levels
of serum TBA compared to male ARE-Del2/2 mice.
However, depletion of Ifnar1 in female ARE-Del2/2
mice significantly reduced serum TBA levels, resulting
in the disappearance of the significant sex difference.
Elevated levels of serum IgM in ARE-Del2/2 mice
were more pronounced in female than male mice (Sup-
porting Fig. S1). Furthermore, and consistent with our
previous report, IgM anti-PDC-E2 and IgM anti-
SP100 were elevated in female ARE-Del2/2 mice
(Supporting Fig. S1). This sex-biased IgM anti-PDC-
E2 and anti-SP100 expression in ARE-Del2/2 mice
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FIG. 2. Serum level of TBA and AMA in
ARE-Del2/2Ifnar12/2 mice. (A) Serum
TBA levels at age 20 (62) weeks in female
and male Ifnar12/2, ARE-Del2/2, ARE-
Del2/2Ifnar12/2 mice compared to WT
littermates (n5 7-8). (B) Serum anti-PDC-
E2 antibodies (IgM and IgG) were detected
by the standard ELISA against recombinant
proteins of PDC-E2. Data represent
mean6SEM. Statistical analysis was per-
formed by one-way ANOVA. ****P< 0.001,
n.s., not significant.
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was no longer present in ARE-Del2/2 Ifnar12/2
mice. Indeed, the serum levels of both IgM and IgG to
PDC-E2 were not significantly different between male
and female ARE-Del2/2 Ifnar12/2 mice (Fig. 2B).
DEPLETION OF TYPE I IFN
RECEPTOR PREVENTS FEMALE-
PREVALENT EXCESSIVE GC
FORMATION IN ARE-Del2/2 MICE
Lymph follicles were diffusely distributed and follic-
ular size was homogeneous in splenic sections of both
sexes of WT mice (Fig. 3). In contrast, various-sized
follicles were observed in spleen of ARE-Del2/2 mice.
Immunohistochemistry PNA staining reflected that
ARE-Del2/2 mice had more PNA-positive GCs than
males, indicating enhanced GC formation; the num-
bers of lymphoid follicles per section was increased in
female ARE-Del2/2 compared to males (Fig. 3B).
We next examined GC B cells in ARE-Del2/2 mice.
GC B cells typically display PNA lectin and express
CD95; therefore, the splenic B2201PNA1CD951B
cells were analyzed by flow cytometry. The frequency
of PNA1CD951 cells was significantly increased in
ARE-Del2/2 mice; deleting the type I IFN receptor
ameliorated the accumulation of GC B cells in spleens
of ARE-Del2/2 mice (Fig. 3C,D). Moreover, in ARE
Del2/2 mice, there is a more diffuse nature of the
GCs as well as loss of the marginal zone B cells. Both
of these features were also rescued by deletion of Ifnar1
(Supporting Fig. S2). These data suggest that sex-
biased GC formation in ARE-Del2/2 mice is depen-
dent on type I IFN in ARE-Del2/2 mice.
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FIG. 3. Female-prevalent GC
formation in ARE-Del2/2 mice.
(A) Representative H&E and
PNA staining of spleen from
ARE-Del2/2 mice of both sexes
at age 20 (62) weeks. (B) GC
numbers was counted on each
entire spleen cross-section with
largest wide and longest diameter,
estimating a same size of each
specimen (mean6 SEM, n5 4-
5). (C) Representative image of
CD95hiPNAhi GC B cells ana-
lyzed by flow cytometry. The gate
of B cells was the B2201 popula-
tion. The image from female
ARE-Del2/2 mice was compared
toWT littermate. (D) Percentages
of B2201CD95hiPNAhiGC B
cells in female Ifnar12/2, ARE-
Del2/2, ARE-Del2/2Ifnar12/2
mice compared to control litter-
mates (mean6 SEM, n5 4-5).
Statistical analysis was performed
by one-way ANOVA. *P< 0.05;
**P< 0.01; ***P< 0.001, n.s., not
significant.
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DISTINCTTfh ANDGCRESPONSES
SEX BIAS ANDTYPE I IFN
GC B cell differentiation and responses are regulated
by Tfh cells,(23,24) and IFN-c has the potential for activa-
tion of Tfh cells.We therefore analyzed the Tfh subpopu-
lation of T cells in the spleen in ARE-Del1/2 mice to
determine whether lower expression of IFN-c could
enhance the reaction and accumulation of Tfh cells in
heterozygous female mice. There are clearly distinct pop-
ulations of pre-Tfh and Tfh cells in ARE-Del1/2 mice
compared to WT mice (Fig. 4A). The frequency of Tfh
cells was more pronounced in female, compared to male,
ARE-Del1/2 mice (Fig. 4B). However, the frequency of
PNA1CD951 GC B cells was not strongly increased in
ARE-Del1/2 mice, andGC abnormalities were less than
observed in ARE-Del2/2 mice. We next analyzed the
frequency of both Tfh cells and GC B cells in ARE-
Del1/2 Ifnar12/2 mice compared to type I IFN
receptor-sufficient ARE-Del1/2 mice. Deletion of the
Ifnar1 gene suppressed the accumulation of both Tfh and
GC B cells in ARE-Del1/2 mice; that is, the frequency
of these cells was not significantly different between
female andmale ARE-Del1/2 Ifnar12/2 mice (Fig. 4B).
ADOPTIVE TRANSFER OF CD4T
CELLS FROM ARE-Del2/2 MICE
LEADS TO SERUM BILE ACID
SECRETION WITH INCREASED
GC RESPONSES
We recently reported that transfer of CD4T
cells, but not CD8T cells, from ARE-Del2/2 to
                                                                                                                                      
FIG. 4. Deletion of the Ifnar1
gene suppresses female-biased
induction of Tfh cells in the spleen
of heterozygous ARE-Del1/2 mice.
(A) Representative image of flow
cytometric analysis of isolated sple-
nocyte populations for Tfh cells
(CD41CXCR5hiPD-1hi) in female
ARE-Del1/2 mice compared to
control littermates. Percentages of
splenic CD41CXCR5hiPD-1hi Tfh
cells (B) and B2201CD95hiPNAhi
GC B cells (C) were analyzed by
flow cytometry from female and
male Ifnar12/2, ARE-Del2/2,
ARE-Del2/2Ifnar12/2 mice com-
pared to control littermates (mean6
SEM, n5 4-5). Statistical analysis
was performed by one-way
ANOVA. *P< 0.05; **P< 0.01,
n.s., not significant. Abbreviations:
Cy5, cyanine 5; PE, phycoerythrin.
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B6/Rag12/2 mice induces PBC-like pathological
changes in their livers.(8) RNA-sequencing of female-
specific gene expression suggested that CD4T cells are
a distinct factor in the pathology observed in female
mice compared to male ARE-Del2/2 mice.(8) A recent
report suggests that IFN-c stimulates GC formation
and development, a process thought to be critical for
autoimmune disease development.(10) Importantly,
IFN-c signaling in intrinsic B cells was shown to be
required for spontaneous GC formation and autoanti-
body generation.(11) We thus examined whether
chronic overexpression of IFN-c in ARE-Del2/2 mice
promotes excessive GC responses. To test the role of
ARE-Del2/2 CD4T cells in GC formation, especially
induction of GC B cell abnormal responses, CD4T
cells from female ARE-Del2/2 mice were transferred
to WT mice. The Tfh and GC B cells in recipient
mice were evaluated by flow cytometric analysis 8 weeks
after cell transfer. Adaptive transfer of CD4T cells
from ARE-Del2/2 mice notably increased GC B cells
in the recipient mice (Fig. 5A). Although the increase
of Tfh cells in spleen of the ARE-Del2/2 transfer
group did not reach statistical significance (Fig. 5A),
there were similar phenotypes of Tfh cells from ARE-
Del mice with high expression of PD-1 in recipient
mice. C57BL/6 mice are Th1 biased, and our data
have shown that some WT mice have a mild induction
of Tfh cells; a distinct population of cells with PD-1
expression was not as clearly distinct as observed in
ARE-Del mice. Thus, the data also support the
hypothesis that the IFN-c activated Tfh cells regulate
differentiation and responses of GC B cells in ARE-
Del2/2 mice. Moreover, TBA secretion was signifi-
cantly up-regulated in recipient mice upon adoptive
transfer of CD4T cells from ARE-Del2/2 mice
(Fig. 5B). In addition, adoptive transfer of CD4T cells
from ARE-Del1/2 mice to recipient WT mice also
increased liver infiltration of T cells, but, interestingly,
an increase in TBA secretion was not detected (data
not shown). These data suggest that Tfh cells gener-
ated from transferred autoreactive CD4T cells induce
excessive GC formation and GC B cell responses. We
propose that this is the initial step in the pathogenesis
of disease in ARE-Del2/2 mice.
Discussion
Female bias is one of the hallmarks of autoimmunity
and remains one of the critical enigmatic issues in
autoimmunity, including PBC.(25,26) Recently, we
have provided evidence that chronic overexpression of
IFN-c leads to sex bias autoimmune cholangitis, which
mimics the characteristics of PBC.(8) However, IFN-c
is promiscuous with a pleiotropic mode of action.(27)
We reasoned, based on our previous data in
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FIG. 5. Adoptive transfer of ARE-Del2/2 CD41 T cells enhances GC responses and TBA secretion in recipient mice. Splenic
CD41 T cells from ARE-Del2/2 mice (KO; n5 6) or from control littermates (WT; n5 3) were adoptively transferred to WT
mice. After 8 weeks, splenocyte populations were isolated and Tfh and GC B cells were analyzed by flow cytometry. (A) Percentages
of CD41CXCR5hiPD-1hi Tfh cells and B2201CD95hiPNAhi GC B cells in spleen from KO to WT mice compared to control
groups. (B) Serum TBA levels were measured from KO to WT mice compared to control groups. Data represent mean6 SD. At least
two independent experiments were performed. Statistical analysis was performed by the unpaired Student t test. *P< 0.05; **P< 0.01;
***P< 0.001, n.s., not significant.
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ARE-Del2/2 mice, that study of the interplay of type
I and type II IFNs was essential to understand our
data and our thesis that such interplay was essential for
female sex bias. Second, we proposed that if our thesis
is correct, then it leads logically to the possible use of
specific therapeutic agents to treat human PBC.
Herein, we demonstrate that, in ARE-Del2/2 mice,
the pathological effects of overexpression of IFN-c and
sex bias is dependent on activation of type I IFN sig-
naling. Indeed, we report that blocking the IFN-a/b
receptor signaling pathway using ARE-Del2/2
Ifnar12/2 (i.e., double-knockout) mice corrects chol-
angitis with direct therapeutic implications.
Type I and type II IFNs have distinct roles in
immune responses through the interaction with spe-
cific cell-surface receptors and activation of classical
Janus kinase/signal transducer and activator of tran-
scription (STAT) signaling.(28) Each receptor is com-
posed of two chains: type I for IFNAR1 and IFNAR2
and type II receptor for IFNGR1 and IFNGR2.
When they bind to their receptors, type I IFN regu-
lates transcription by the STAT2-STAT1 heterodimer
complex whereas type II IFN requires STAT1 homo-
dimer formation. It is well known that there are
defined different consequences of altering interferon
production and metabolism, that is, blockade leads to
clinically significant cellular responses. These data are
derived by use of both neutralizing antibodies and in
mice-specific receptor gene deletion.(29-31) For exam-
ple, protective antiviral effects of IFN-c are reduced or
eliminated in Ifnar1 knockout fibroblasts, that is, by
preventing type I IFN priming.(29) Our previous data
revealed that increased expression of IFN-c by replace-
ment of the AU-rich region potentially activates type I
interferon signaling.(9) In our study, deletion of the
type I IFN receptor in ARE-Del2/2 mice dramatically
reduces cholangitis, suggesting that IFN-c-activated
type I IFNs synergize with IFN-c-mediated cellular
responses.
Although the molecular and cellular mechanisms for
the cross-talk of type I and II IFNs are not well under-
stood, the STAT1-mediated signaling pathway is
thought to be a regulating factor because low levels of
type I IFN primes IFN-c-mediated immune responses
by modulating sufficient STAT1 expression in mouse
fibroblasts.(29,32) For this reason, we first compared
STAT1 expression in male and female ARE-Del2/2
mice, expecting that female ARE-Del2/2 mice would
have stronger STAT1 expression than male mice.
However, we did not see significant sex differences of
STAT1 protein expression in the liver of ARE-Del2/2
mice (data not shown). Based on liver gene expression
profiles in ARE-Del2/2 mice, the earliest events in
PBC may lead to up-regulation of both type I and II
IFN and, consequently, modulate major histocompati-
bility class (MHC) class II expression in both male
and female mice. However, female ARE-Del2/2 mice
would have enhanced IFN signaling that is likely
involved in CD4 helper T-cell-mediated cellular
responses. Hence, it can be reasoned that STAT1 is a
central modulator for the MHC class II expression in
disease progression, and, importantly, STAT1-
independent pathways would be required for female
gender bias.
Type I and type II IFN signaling regulates several
X-chromosome-encoded, immune-related genes,
which may subsequently influence the immune
response in a sex-dependent manner.(33,34) Thus, we
compared X-chromosome-encoded, immune-related
genes with our hepatic gene expression data in female
ARE-Del2/2 mice.(8) Interestingly, female specific
differentially expressed genes overlapped with many
X-chromosome-encoded, immune-related genes,
including CXCR3, Toll-like receptor (TLR) 7, TLR8,
interleukin (IL) 2G, glucose-6-phosphate 1-dehydro-
genase, GRB2-associated binding protein 3, Rac/
Cdc42 guanine nucleotide exchange factor 6, Rho
GTPase activating protein 6, properdin P factor,
colony-stimulating factor 2 receptor alpha subunit, and
IL3RA. Further pathway analysis demonstrated that
plasmacytoid dendritic cells (pDCs), a major source of
IFN-a, is a potential cellular target. Several studies
have noted that female-biased production of IFN-a by
pDCs may lead to sex-biased infection and autoimmu-
nity.(35-38) Therefore, female-biased induction of IFN-
a by pDCs in ARE-Del mice may play a role in this
sex-biased PBC-like disease.
Deletion of B cell-intrinsic IFN-c receptor and
TLR7 dramatically suppressed spontaneous GCs and
the production of pathogenic autoantibodies in a
murine model of lupus.(39) In our preliminary data,
deletion of TLR7 rescued GC formation and patho-
logical phenotypes, which correlated with deletion of
the type I IFNAR chain (Supporting Fig. S2). Impor-
tantly, IFNAR signals can potentially block TLR7 tol-
erance in both murine and human B cells. This
regulation of TLR7 tolerance and activation is depen-
dent on activation of the phosphoinositide 3-kinase
(PI3K)/protein kinase B (Akt)/mammalian target of
rapamycin (mTOR) signaling pathway in B cells.(40)
Considering that STAT1-independent distinct signal-
ing pathways, that is, mitogen-activated protein kinase
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(MAPK) p38 and PI3K/AKT/mTOR, are indispens-
able for type I and II IFNs responses,(28) we propose
that future studies should examine signaling cascades
and sex differences. Given that IFN-c distorts the
lysosomal localization of mTOR inhibiting its activa-
tion by, that is, PI3K-AKT upstream signaling,(41)
altered PI3K/AKT/mTOR signaling pathways may
critically affect IFN-c-mediated cellular and molecular
responses in specific cell types. Within this view, our
previous hepatic gene expression between male and
female ARE-Del2/2 mice at 20 weeks of age indicated
that females manifest activated MAPK p38 and the
PI3K/AKT/mTOR signaling pathways(8) (Supporting
Fig. S4). Moreover, suppressor of cytokine signaling
inhibition was found only in female mice, indicating
that Stat-Jak signaling was inhibited by negative feed-
back in female ARE-Del2/2 mice. Hence, we propose
that drugs that inhibit Jak-Stat signaling pathways
have potential utility in treating PBC during stages of
activated T-cell infiltration.
Of note, the sex bias of Tfh and GC responses in
both homozygotes and heterozygotes were type I IFN
dependent, but homozygote ARE-Del mice have over-
all higher GC responses than heterozygotes. It is possi-
ble that the GC B cell reaction is the initial step in loss
of B-cell tolerance, given that total B cells were clearly
suppressed in ARE-Del2/2 mice, but not ARE-Del1/2
mice, compared to control littermates. Furthermore, a
more significant difference in female compared to male
ARE-Del mice was observed (Supporting Fig. S3).
Based on our previous report, homozygotes have auto-
antibodies to nuclear DNA and higher Ig class switch-
ing,(12) indicating that homozygotes have a more
specific GC response than heterozygotes. Importantly,
macrophage depletion in heterozygotes by clodronate-
containing liposomes generates autoantibodies to
nuclear DNA, which implies that not only autoreactive
CD4T cells, but also impaired clearance of apoptotic
cells by macrophages in GC may play critical roles in
an enhanced GC response in homozygotes.(42,43)
Our previous cell transfer results support the thesis
that CD4T cells are critical for progression of PBC
and suggest that IFN-c-induced Th1 responses by
CD4T-cell activation drives the sex-biased progres-
sion of PBC.(8) In this study, we demonstrated that
transfer of ARE-Del2/2 CD4T cells leads to appear-
ance of abnormal Tfh cells, which have been shown to
have the potential to change GC to excessively respond
and elicit autoreactive GC B cells. Conversely, B-cell-
intrinsic IFN-c receptor signaling is also required for
spontaneous GC formation and pathogenic Tfh cell
development.(11) Therefore, it is logical to conclude
that IFN-c cross-talk between B and Tfh cells in the
GC plays a role in loss of B-cell tolerance. It should be
noted nonetheless that serum TBA levels in serum
were statistically elevated only in female ARE-Del2/2
mice, indicating that a threshold level of IFN-c may be
a requisite for abnormal TBA secretion. On the other
hand, serum bile acid levels may only reflect the extent
of biliary damage. Homozygous ARE-Del mice also
develop higher levels of autoantibodies than heterozy-
gous ARE-Del mice, and female ARE-Del2/2 mice
have more IgM reactivity. It has been proposed that
leakage of hydrophobic bile acids into the periductal
area may be cytopathic for biliary epithelial cells.(44)
Therefore, the higher level observed herein of bile acids
may become a secondary factor in the perpetuation of
disease in ARE-Del2/2 mice.
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